COMMUNIQUÉS West-GlobeNewswire

DBV Technologies Announces Closing of Underwriters' Option to Purchase Additional Shares in Global Offering
26/03/2018
Montrouge, France, March 26, 2018 DBV Technologies Announces Closing of Underwriters' Option to Purchase Additional Shares in Global Offering DBV Technologies (the "Company") (Euronext: DBV - ISIN: FR0010417345 - Nasdaq [...]
DBV Technologies annonce le règlement-livraison des actions ordinaires supplémentaires au titre de l'exercice de la totalité de l'option de surallocation dans le cadre de son offre globale
26/03/2018
Montrouge, France, le 26 Mars (22h00 CEST), 2018 DBV Technologies annonce le règlement-livraison des actions ordinaires supplémentaires au titre de l'exercice de la totalité de l'option de surallocation dans le cadre de [...]
argenx announces Annual General Meeting of Shareholders on May 8, 2018
26/03/2018
March 26, 2018 Breda, the Netherlands - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]
MacroGenics Announces Proposed Public Offering of Common Stock
26/03/2018
ROCKVILLE, MD, March 26, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
Profound Medical Corp. Announces Fourth Quarter and Full Year 2017 Financial Results
26/03/2018
TORONTO, March 26, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
CRISPR Therapeutics Announces the Retirement of Tyler Dylan-Hyde and Appointment of Shelby Walker as Head of Intellectual Property
26/03/2018
ZUG, Switzerland and CAMBRIDGE, Mass., March 26, 2018 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP ), a biopharmaceutical company focused on developing transformative gene-based medicines for serious diseases, [...]
Data From TOPACIO Trial Reported at SGO Demonstrates Compelling Clinical Activity of ZEJULA in Combination With an Anti-PD-1 Antibody in Patients With Platinum Resistant/Refractory Ovarian Cancer
26/03/2018
Efficacy of niraparib in combination with an anti-PD-1 mAb surpasses historical efficacy benchmarks for PD-1 or PARP monotherapies in difficult-to-treat types of ovarian cancer, regardless of biomarker status Potential [...]
Stage 3 Meaningful Use Certification Achieved by PracticeSuite EHR
26/03/2018
SILICON VALLEY, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- Cloud based medical office platform PracticeSuite announced today it has achieved Stage 3 Meaningful Use certification of its electronic health record (EHR) [...]
Medical Cannabis Protections Extended to 46 States
26/03/2018
ALBUQUERQUE, New Mexico, March 26, 2018 (GLOBE NEWSWIRE) -- Medical cannabis patients and businesses are protected from federal intervention after President Trump signed the country’s new spending bill into law Friday. [...]
MJ Biotech Inc. Q & A Update w/ Doctor Interview
26/03/2018
CHEYENNE, Wyo., March 26, 2018 (GLOBE NEWSWIRE) -- MJ Biotech, Inc. (FKA Michael James Enterprises, Inc.) (OTC:MJTV) announced that the interview with Maxine Pierson CEO of MJ Biotech, Inc and Fernando Lopez COO of MJ [...]
Ossur Hf : Transactions in relation to share buyback program
26/03/2018
Announcement no. 23/2018 Reykjavik, 26 March 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]
Physeon Reports Positive Clinical Trial Results for its Veinplicity Device
26/03/2018
SCHAFFHAUSEN, Switzerland, March 26, 2018 (GLOBE NEWSWIRE) -- Physeon GmbH (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, today announced positive results from its [...]
Preclinical Data Showing Synergy of Biothera Pharmaceuticals’ Imprime PGG and a CD40 Agonist in a Pancreatic Cancer Model Presented at Keystone Symposia
26/03/2018
EAGAN, Minn., March 26, 2018 (GLOBE NEWSWIRE) -- Biothera Pharmaceuticals, Inc. and the Abramson Cancer Center of the University of Pennsylvania announced today the presentation of new preclinical data demonstrating the [...]
Puerto Rican Alzheimer’s Patients to Be First in U.S. to Obtain Cannabis-Based Relief
26/03/2018
BETHESDA, Md. and SAN JUAN, Puerto Rico, March 26, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) – Alzheimer’s patients in Puerto Rico will be the first in the United States to obtain [...]
FDA approves inclusion of data on cardiovascular outcomes and severe hypoglycaemia in the Tresiba® label
26/03/2018
Bagsværd, Denmark, 26 March 2018 - Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved an update to the US prescribing information for Tresiba ® (insulin degludec) to include data [...]
Millennium BlockChain Announces Major Investment in Online Broker Dealer ChoiceTrade
26/03/2018
Millennium BlockChain, first publicly traded company to conduct stock swaps for equity in blockchain companies, partners with ChoiceTrade to introduce the next generation of trading LAS VEGAS / SAN JUAN, PUERTO RICO, [...]
iKang Enters into Definitive Merger Agreement for Going Private Transaction
26/03/2018
BEIJING, March 26, 2018 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. (“iKang” or the “Company”) (Nasdaq: KANG ), a major provider in China’s fast growing private preventive healthcare services market, today [...]
TOMI Environmental Solutions, Inc. Secures EPA Registration in Taiwan
26/03/2018
BEVERLY HILLS, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc. (“TOMI”) (OTCQX:TOMZ) a global company that specializes in plasma science based disinfection/decontamination technology using [...]
CohBar, Inc. Announces Financing of up to US$5,000,000 in Unsecured Promissory Notes
26/03/2018
MENLO PARK, Calif., March 26, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ: CWBR ) and (TSXV:COB.U) (“CohBar” or the “Company”), a preclinical stage biotechnology company developing mitochondria based therapeutics to [...]

Pages